Brahman Capital Corp. Teva Pharmaceutical Industries LTD Transaction History

Brahman Capital Corp.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$8.57 - $12.69 $11.2 Million - $16.5 Million	-1,303,003 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $804,846 - $1.3 Million	-99,119 Reduced 7.07%	1,303,003 $16.1 Million
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $3.73 Million - $7.5 Million	-557,878 Reduced 28.46%	1,402,122 $12.6 Million
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $12.8 Million - $21 Million	1,960,000 New	1,960,000 $19.2 Million
Q2 2019 Aug 14, 2019	SELL	$8.12 - $15.72 $57.4 Million - $111 Million	-7,064,540 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $80.8 Million - $104 Million	-5,183,566 Reduced 42.32%	7,064,540 $111 Million
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $71.9 Million - $117 Million	4,925,245 Added 67.26%	12,248,106 $189 Million
Q3 2018 Nov 14, 2018	SELL	$21.06 - $25.65 $69 Million - $84 Million	-3,274,818 Reduced 30.9%	7,322,861 $158 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $28.4 Million - $41.9 Million	-1,694,721 Reduced 13.79%	10,597,679 $258 Million
Q1 2018 May 15, 2018	BUY	$16.68 - $22.07 $39.1 Million - $51.8 Million	2,346,888 Added 23.6%	12,292,400 $210 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $112 Million - $190 Million	9,945,512	9,945,512 $188 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Brahman Capital Corp., based on Form 13F filings with the SEC.

Stay updated on Brahman Capital Corp. with notifications on news.